Safety of mechanical lung vibrator and high‐frequency chest wall oscillation in patients with cardiac implantable electronic device

BACKGROUND: Chest physiotherapy (CPT) is a non‐pharmacological therapy to facilitate airway secretion removal. There have been concerns about potential electromagnetic interference (EMI) and lead integrity problems during the use of vibrating CPT devices in patients with cardiac implantable electronic devices (CIEDs). HYPOTHESIS: Two CPT devices can be used safely in patients with CIED. METHODS: Volunteer patients with CIED underwent device interrogation to check lead integrity and device function before and after application of CPT devices. Mechanical lung vibrator and high‐frequency chest wall oscillation (HFCWO) vests were used while monitoring surface electrocardiograms and intra‐cardiac electrograms. RESULTS: We prospectively enrolled 46 patients with CIEDs (25 pacemakers, 15 implantable cardioverter‐defibrillators, and six cardiac resynchronization therapy‐defibrillators). There was no noise detection or EMI during CPT in any patient. None of the patients showed clinically significant changes in lead integrity parameters. HFCWO inappropriately accelerated the pacing rate up to the maximal programmed value in five patients with pacemakers and two with cardiac resynchronization therapy‐defibrillators. CONCLUSION: CPT may be safely applied to patients with CIED without compromising lead integrity or device function, except for unwanted increase in pacing rate caused by misdetection of chest wall vibration as patients' activity while using HFCWO. Deactivation of the accelerometer‐based activity sensor may be needed when HFCWO is planned for CPT.